These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23382873)

  • 1. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel.
    Liu H; Chatel S; Simard C; Syam N; Salle L; Probst V; Morel J; Millat G; Lopez M; Abriel H; Schott JJ; Guinamard R; Bouvagnet P
    PLoS One; 2013; 8(1):e54131. PubMed ID: 23382873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPM4 mutations to cause autosomal recessive and not autosomal dominant Brugada type 1 syndrome.
    Janin A; Bessière F; Georgescu T; Chanavat V; Chevalier P; Millat G
    Eur J Med Genet; 2019 Jun; 62(6):103527. PubMed ID: 30142439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient receptor potential melastatin 4 cation channel in pediatric heart block.
    Tian J; An XJ; Fu MY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(4 Suppl):79-84. PubMed ID: 29165759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-specific effects of lidocaine in Brugada syndrome.
    Clancy CE; Wehrens XH
    Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.
    Keller DI; Rougier JS; Kucera JP; Benammar N; Fressart V; Guicheney P; Madle A; Fromer M; Schläpfer J; Abriel H
    Cardiovasc Res; 2005 Aug; 67(3):510-9. PubMed ID: 15890323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum in the Ca(2+)--activated cation channel gene TRPM4 in patients with cardiac conductance disturbances.
    Stallmeyer B; Zumhagen S; Denjoy I; Duthoit G; Hébert JL; Ferrer X; Maugenre S; Schmitz W; Kirchhefer U; Schulze-Bahr E; Guicheney P; Schulze-Bahr E
    Hum Mutat; 2012 Jan; 33(1):109-17. PubMed ID: 21887725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.
    Gualandi F; Zaraket F; Malagù M; Parmeggiani G; Trabanelli C; Fini S; Dang X; Wei X; Fang M; Bertini M; Ferrari R; Ferlini A
    Cardiology; 2017; 137(4):256-260. PubMed ID: 28494446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
    Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brugada syndrome.
    Napolitano C; Priori SG
    Orphanet J Rare Dis; 2006 Sep; 1():35. PubMed ID: 16972995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPM4 channels in the cardiovascular system.
    Kruse M; Pongs O
    Curr Opin Pharmacol; 2014 Apr; 15():68-73. PubMed ID: 24721656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
    Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
    Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.